Atlas Trials

Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)

Clinical trial NCT00978367 · COMPLETED

Trial details

NCT number
NCT00978367
Sponsor
Renovo
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
CicatrixWound HealingRe-epithelialization
Start date
2002-02-01
Primary completion
2002-11-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.